• 1
    Schroeder JT, Kagey-Sobotka A, Lichtenstein LM. The role of the basophil in allergic inflammation. Allergy 1995; 50 : 463.
  • 2
    Abraham SN, Arock M. Mast cells and basophils in innate immunity. Semin Immunol 1998; 10 : 373.
  • 3
    Chang TW. The pharmacological basis of anti-IgE therapy. Nat Biotechnol 2000; 18 : 157.
  • 4
    MacGlashan D Jr, McKenzie-White J, Chichester K, Bochner BS, Davis FM, Schroeder JT, Lichtenstein LM. In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody. Blood 1998; 91 : 1633.
  • 5
    Schroeder JT, MacGlashan DW Jr. New concepts: the basophil. J Allergy Clin Immunol 1997; 99 : 429.
  • 6
    Ochensberger B, Rihs S, Brunner T, Dahinden CA. IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. Blood 1995; 86 : 4039.
  • 7
    Iikura M, Yamaguchi M, Fujisawa T et al. Secretory IgA induces degranulation of IL-3-primed basophils. J Immunol 1998; 161 : 1510.
  • 8
    Schroeder JT, MacGlashan DW Jr, Kagey-Sobotka A, White JM, Lichtenstein LM. Cytokine generation by human basophils. J Allergy Clin Immunol 1994; 94 : 1189.
  • 9
    MacGlashan D Jr, White JM, Huang SK, Ono SJ, Schroeder JT, Lichtenstein LM. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1994; 152 : 3006.
  • 10
    Li H, Sim TC, Grant JA, Alam R. The production of macrophage inflammatory protein-1 alpha by human basophils. J Immunol 1996; 157 : 1207.
  • 11
    Rothenberg ME, Owen WF Jr, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL. Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 1988; 81 : 1986.
  • 12
    Walsh GM. Mechanisms of human eosinophil survival and apoptosis. Clin Exp Allergy 1997; 27 : 482.
  • 13
    Park BS, Kim GC, Back SJ et al. Murine bone marrow-derived mast cells exhibit evidence of both apoptosis and oncosis after IL-3 deprivation. Immunol Invest 2000; 29 : 51.
  • 14
    Berardi AC, Wang A, Levine JD, Lopez P, Scadden DT. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267 : 104.
  • 15
    Blalock WL, Weinstein-Oppenheimer C, Chang F et al. Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs. Leukemia 1999; 13 : 1109.
  • 16
    Scheid MP, Lauener RW, Duronio V. Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte–macrophage colony-stimulating factor. Biochem J 1995; 312 : 159.
  • 17
    Songyang Z, Baltimore D, Cantley LC, Kaplan DR, Franke TF. Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci USA 1997; 94 : 11345.
  • 18
    Del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997; 278 : 687.
  • 19
    Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase[see comments]. Nature 1999; 401 : 82.
  • 20
    Besancon F, Atfi A, Gespach C, Cayre YE, Bourgeade MF. Evidence for a role of NF-kappaB in the survival of hematopoietic cells mediated by interleukin 3 and the oncogenic TEL/platelet-derived growth factor receptor beta fusion protein. Proc Natl Acad Sci USA 1998; 95 : 8081.
  • 21
    Lopez-Cabrera M, Munoz E, Blazquez MV, Ursa MA, Santis AG, Sanchez-Madrid F. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-alpha-responsive elements. J Biol Chem 1995; 270 : 21545.
  • 22
    Blazquez MV, Macho A, Ortiz C, Lucena C, Lopez-Cabrera M, Sanchez-Madrid F, Munoz E. Extracellular HIV type 1 Tat protein induces CD69 expression through NF-kappaB activation: possible correlation with cell surface Tat-binding proteins. AIDS Res Hum Retroviruses 1999; 15 : 1209.
  • 23
    Marzio R, Mauel J, Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 1999; 21 : 565.
  • 24
    Matsumoto K, Appiah-Pippim J, Schleimer RP, Bickel CA, Beck LA, Bochner BS. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am J Respir Cell Mol Biol 1998; 18 : 860.
  • 25
    Julius P, Luttmann W, Knoechel B, Kroegel C, Matthys H, Virchow JC Jr. CD69 surface expression on human lung eosinophils after segmental allergen provocation. Eur Respir J 1999; 13 : 1253.
  • 26
    Toba K, Koike T, Shibata A et al. Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophils. Cytometry 1999; 35 : 249.
  • 27
    Ochensberger B, Tassera L, Bifrare D, Rihs S, Dahinden CA. Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists. Eur Respir J 1999; 29 : 11.
  • 28
    Lantz CS, Boesiger J, Song CH et al. Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 1998; 392 : 90.
  • 29
    Valent P, Schmidt G, Besemer J et al. Interleukin-3 is a differentiation factor for human basophils. Blood 1989; 73 : 1763.
  • 30
    Yamaguchi M, Hirai K, Shoji S, Takaishi T, Ohta K, Morita Y, Suzuki S, Ito K. Haemopoietic growth factors induce human basophil migration in vitro. Clin Exp Allergy 1992; 22 : 379.
  • 31
    Yamaguchi M, Hirai K, Ohta K et al. Nonreleasing basophils convert to releasing basophils by culturing with IL-3. J Allergy Clin Immunol 1996; 97 : 1279.
  • 32
    Yamaguchi M, Hirai K, Morita Y et al. Hemopoietic growth factors regulate the survival of human basophils in vitro. Int Arch Allergy Immunol 1992; 97 : 322.
  • 33
    Tsang S, Hayashi M, Zheng X, Campbell A, Schellenberg RR. Simplified purification of human basophils. J Immunol Methods 2000; 233 : 13.
  • 34
    Zheng X, Knight DA, Zohou D, Weir T, Peacock C, Schellenberg RR, Bai TR. Leukemia inhibitory factor is synthesized and released by human eosinophils and modulates activation state and chemotaxis. J Allergy Clin Immunol 1999; 104 : 136.
  • 35
    Walker BA, Rocchini C, Boone RH, Ip S, Jacobson MA. Adenosine A2a receptor activation delays apoptosis in human neutrophils. J Immunol 1997; 158 : 2926.
  • 36
    Walker DC, Behzad AR, Chu F. Neutrophil migration through preexisting holes in the basal laminae of alveolar capillaries and epithelium during streptococcal pneumonia. Microvasc Res 1995; 50 : 397.
  • 37
    Schedle A, Samorapoompichit P, Fureder W et al. Metal ion-induced toxic histamine release from human basophils and mast cells. J Biomed Mater Res 1998; 39 : 560.
  • 38
    Hartnell A, Robinson DS, Kay AB, Wardlaw AJ. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 1993; 80 : 281.
  • 39
    Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991; 78 : 2542.
  • 40
    Denburg JA, Woolley M, Leber B, Linden M, O'Byrne P. Basophil and eosinophil differentiation in allergic reactions. J Allergy Clin Immunol 1994; 94 : 1135.
  • 41
    Koshino T, Arai Y, Miyamoto Y et al. Airway basophil and mast cell density in patients with bronchial asthma: relationship to bronchial hyperresponsiveness. J Asthma 1996; 33 : 89.
  • 42
    Miyajima A, Mui AL, Ogorochi T, Sakamaki K. Receptors for granulocyte–macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993; 82 : 1960.
  • 43
    Nishikawa K, Morii T, Ako H, Hamada K, Saito S, Narita N. In vivo expression of CD69 on lung eosinophils in eosinophilic pneumonia: CD69 as a possible activation marker for eosinophils. J Allergy Clin Immunol 1992; 90 : 169.
  • 44
    Luttmann W, Knoechel B, Foerster M, Matthys H, Virchow JC Jr, Kroegel C. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability. J Immunol 1996; 157 : 1678.
  • 45
    Ramirez R, Carracedo J, Castedo M, Zamzami N, Kroemer G. CD69-induced monocyte apoptosis involves multiple nonredundant signaling pathways. Cell Immunol 1996; 172 : 192.
  • 46
    Walsh GM, Williamson ML, Symon FA, Willars GB, Wardlaw AJ. Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte–macrophage colony-stimulating factor. Blood 1996; 87 : 2815.
  • 47
    Karin M. The NF-kappa B activation pathway: its regulation and role in inflammation and cell survival. Cancer J Sci Am 1998; 4 : S92.
  • 48
    Duriez PJ, Wong F, Dorovini-Zis K, Shahidi R, Karsan A. A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. J Biol Chem 2000; 275 : 18099.
  • 49
    Cui H, Matsui K, Omura S, Schauer SL, Matulka RA, Sonenshein GE, Ju ST. Proteasome regulation of activation-induced T cell death. Proc Natl Acad Sci USA 1997; 94 : 7515.
  • 50
    Sasaki T, Irie-Sasaki J, Jones RG et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration[see comments]. Science 2000; 287 : 1040.
  • 51
    Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997; 385 : 544.
  • 52
    Scheid MP, Duronio V. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc Natl Acad Sci USA 1998; 95 : 7439.
  • 53
    Shimamura A, Ballif BA, Richards SA, Blenis J. Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr Biol 2000; 10 : 127.
  • 54
    Ochiai K, Tanabe E, Ishihara C, Kagami M, Sugiyama T, Sueishi M, Koya N, Tomioka H. Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma). Clin Exp Immunol 1999; 118 : 340.